2023/02/03 18:00:00 | |
---|---|
Price | |
30.376 CHF | |
Difference | 6.24% (1.78) |
ISIN | SE0000695876 |
Symbol | ALFA |
Exchange | BX Swiss |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 13,132 EUR |
Benchmark | OMX STOCKHOLM 30 INDEX |
Bid (Bid size) | 31.574 CHF (1,663) |
Ask (Ask size) | 31.633 CHF (1,663) |
Open | 30.376 CHF |
High | 30.376 CHF |
Low | 30.376 CHF |
Close (prev. day) | 28.592 CHF |
VWAP | 30.376 CHF |
Volume (pcs) | 15 |
Trading volume | 455.60 |
Number of trades | 1 |
Last size | 15 |
Related Futures | 50 |
Related Options | - |
Date | Headline | Download | |
2023/03/28 |
![]() |
Global Equity Ratings |
![]() |
2023/03/16 |
![]() |
Global Equity Ratings |
![]() |
2023/03/10 |
![]() |
Global Equity Ratings |
![]() |
2023/02/27 |
![]() |
Global Equity Ratings |
![]() |
2023/02/07 |
![]() |
Global Equity Ratings |
![]() |
2023/02/03 18:00:00 | |
---|---|
Price | |
30.376 CHF | |
Difference | 6.24% (1.78) |
ISIN | SE0000695876 |
Symbol | ALFA |
Exchange | BX Swiss |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 13,132 EUR |
Benchmark | OMX STOCKHOLM 30 INDEX |
Bid (Bid size) | 31.574 CHF (1,663) |
Ask (Ask size) | 31.633 CHF (1,663) |
Open | 30.376 CHF |
High | 30.376 CHF |
Low | 30.376 CHF |
Close (prev. day) | 28.592 CHF |
VWAP | 30.376 CHF |
Volume (pcs) | 15 |
Trading volume | 455.60 |
Number of trades | 1 |
Last size | 15 |
6m | 1Y | 3Y | |
Perf (%) | - | - | - |
Perf (abs.) | - | - | - |
Beta | 1.29 | 1.26 | 1.17 |
Volatility | 68.48 | 68.48 | 68.48 |
Ø price 5 days | Ø volume 5 days (pcs.) | - CHF (23) |
Ø price 30 days | Ø volume 30 days (pcs.) | - CHF (23) |
Ø price 100 days | Ø volume 100 days (pcs.) | - CHF (23) |
Ø price 250 days | Ø volume 250 days (pcs.) | - CHF (23) |
YTD High | date | 30.376 CHF (2023/02/03) |
YTD Low | date | 28.592 CHF (2023/01/17) |
52 Weeks High | date | 30.376 CHF (2023/02/03) |
52 Weeks Low | date | 28.592 CHF (2023/01/17) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2023/03/30 | 15:01 | 31.60 EUR | 0.02 | 8 |
Stuttgart | 2023/03/30 | 15:46 | 31.46 EUR | 0.00 | 3 |
Nasdaq Stockholm | 2023/03/30 | 15:51 | 358.00 SEK | 92.13 | 1,476 |
Munich | 2023/03/30 | 14:37 | 31.68 EUR | 0.00 | 2 |
London Stock Exchange European Trade Reporting | 2023/03/30 | 09:00 | 357.75 SEK | 0.00 | 1 |
Hanover | 2023/03/30 | 08:01 | 31.47 EUR | 0.00 | 1 |
Frankfurt | 2023/03/30 | 09:05 | 31.64 EUR | 0.00 | 1 |
FINRA other OTC Issues | 2023/03/27 | 15:34 | 33.48 USD | 0.01 | 1 |
Duesseldorf | 2023/03/30 | 08:10 | 31.59 EUR | 0.00 | 1 |
Berlin | 2023/03/30 | 08:03 | 31.67 EUR | 0.00 | 1 |
BX Swiss | 2023/02/03 | 18:00 | 30.376 CHF | 0.00 | 1 |
ALFA LAVAL AB |
- - |
Rudeboksvagen 3 221 00 Lund |
Telefon: +46 46 367 000 |
Fax: +46 46 306 860 |
E-mail: kundcenter.sverige@alfalaval.com |
- |
Tom Erixon | Chairman of Managing Board |
Emma Adlerton | Member of Executive Committee |
Jan Allde | Member of Executive Committee |
Joakim Vilson | Member of Executive Committee |
Mikael Tydén | Member of Executive Committee |
Nish Patel | Member of Executive Committee |
Pascale Gimenez | Member of Executive Committee |
Sameer Kalra | Member of Executive Committee |
Thomas Møller | Member of Executive Committee |
Dennis Jönsson | Chairman of Supervisory Board |
Bror Lantz | Member of Supervisory Board |
Finn Anders Egil Rausing | Member of Supervisory Board |
Henrik Nielsen | Member of Supervisory Board |
Henrik Gunnar Lange | Member of Supervisory Board |
Johan Ranhög | Member of Supervisory Board |
Jörn Rausing | Member of Supervisory Board |
Lilian Margareta Fossum Biner | Member of Supervisory Board |
Maria Moræus Hanssen | Member of Supervisory Board |
Ray Michael Mauritsson | Member of Supervisory Board |
Ulf Arne Wiinberg | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer